| Summary: | This authoritative volume brings together leading experts from the fields of psychiatry and neurology to present their latest findings on the use of antidepressants in the treatment of various somatic and anxiety disorders. It provides a comprehensive review of the therapeutic efficacy of typical as well as newer antidepressant drugs in relieving depressive symptoms in patients affected by anxiety disorders, eating disorders, schizophrenia, dementia, cardiovascular diseases and cancer. Health economics, social aspects, and cost benefit issues are also thoroughly discussed. Not only will psychiatrists, neurologists, pharmacologists, and psychologists find it a valuable source of new information, but also marketing and medical representatives in pharmaceutical industries and health regulatory authorities
|
|---|